Access Menu

Log in via Social

Log in with LinkedIn
AITOPYA

AITOPYA

Your Personal A.I. Doctor - AITOPYA. Providing free, equal healthcare, anywhere at any time.

Verify Investor Status to make a reservation

Deal Type

Equity

Funding Goal

$2,500,000

Current Reservations

$1,200,000

Minimum Reservation

$2,000,000

Maximum Reservation

$3,000,000

Deal Stage

Seed

Pre-money Valuation

$9,500,000

Open Date

06/01/2019

Closing Date

08/31/2019

Elevator Pitch

A Swedish med-tech company developing a consumer healthcare app, a Personal A.I. Doctor called AITOPYA. Currently raising $2.5M USD in our Seed round where our lead VC is committed to 50%.

KPIs

20 Employees
10,000 Users

Company Overview

We are a Swedish med-tech company developing a consumer healthcare app, a Personal A.I. Doctor called AITOPYA. Our vision is to make healthcare a right and not a privilege by focusing on a huge problem within the healthcare industry: misdiagnosis.

1/3 of all patients around the world are being misdiagnosed every year. These Misdiagnoses are costing healthcare billions of dollars and causing suffering and even deaths every day. This is especially becoming a bigger problem in the emerging markets.

AITOPYA prevents and identifies diagnoses in time to save lives and increase access to healthcare. It is a smartphone application with a consumer focus that gives you instant access to healthcare 24/7 through the power of A.I.:

  • Prevents - possible diseases even when you’re healthy by monitoring your health 24/7
  • Self-diagnostics - Identify possible diseases when you have health problems by inputting your health data with a diagnostic accuracy of 92%. It then provides self-care recommendations so you can take care of it from the comfort of your home.
  • Connects you to the right health professional - if you’re in need of medical attention - like a booking.com for healthcare.
  • Assisting health professionals - by transferring and analyzing your health data to partnering clinics that facilitates diagnostic decision making and administration. They can also interact with you through video and chat in AITOPYA.

AITOPYA outperforms its competitors with a 92% diagnostic accuracy and with its unique integration towards clinics and health professionals.

We've raised $1M USD to date and we are now initiating our Seed round for further growth and development.

Traction

  • 10,000 monthly users and 103 health professionals connected to AITOPYA!

    July, 2019
  • 200% MoM growth since launch in February 2019.

    July, 2019

Press Mentions

Key Customers & Partners

Tieto One world health

Previous Funding

  • $450,000 Equity
  • Raise Source: Investors
  • January 2019
  • $450,000 Equity
  • Raise Source: Investors
  • February 2018
  • $90,000 Equity
  • Raise Source: Investors
  • August 2017

Risks & Disclosures

This investment proposal has been prepared in connection with the Company's offer for subscription of shares in BYON8 AB (hereinafter the Company) corp. identity number 559027-2430.

An investment in shares is associated with certain risks. When investors make a decision to invest, they must rely on their own assessment of BYON8 and this proposal, including the presented facts and risks. Prior to an investment decision, potential investors should acquire the knowledge that is the prerequisite for a well-informed investment decision.

This investment proposal is available on the Company's website www.aitopya.com. The offer under this proposal is not addressed to persons who through participation expects prospectuses, targeted offers or other measures than those arising due to Swedish laws, rules and regulations.

The forecasts and claims communicated in this proposal reflect the board of BYON8's perception of future events as well as financial and operational development, at the time of writing this proposal. Although the Board of Directors considers that the above-mentioned forecasts are considered accurate (to the best of our knowledge), there is no guarantee that the forecast is correct.

The Board is responsible for this proposal and has taken all reasonable precautions to ensure that the information provided in this IM is, to the best of its knowledge, in accordance with the actual circumstances and that nothing has been omitted likely to affect the assessment of the company.

The proposal contains information retrieved from external sources. All such information has been reproduced correctly. Although the Board believes that these sources are reliable, no independent verification has been conducted, so the accuracy or completeness of the information cannot be guaranteed. No information has been deliberately omitted in a manner that would render the rendered information incorrect or misleading.

Documents

Confidential

Loading...